DELIVERY ORDER
Active75F40126F80077
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$349.8K
obligated · signed 3 months ago
CDER PHASE II FOR BIOSIMILARS EDUCATION AND OUTREACH INITIATIVE
Performance timeline
Start
Jul 1, 2026
Current end
Jun 30, 2027
Potential end
Jun 30, 2031
with all options
Loading status
Estimated start: Jun 30, 2030
IQ SOLUTIONS, INC.
Contract 75F40126F80077
UEI
HKS1BN6QXJ95
Parent Company
IQ SOLUTIONS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$349,770
Base + Exercised Options
$349,770
Total Ceiling Value
$1,873,191
Contract Type
TIME AND MATERIALS
NAICS
MARKETING CONSULTING SERVICES
PSC
SPECIAL STUDIES/ANALYSIS- EDUCATIONAL
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
HHS PHS FOOD AND DRUG ADMIN
Office
Contract Vehicle
GS00F083CA
FSSGeneral Services Administration
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.